** Resonance Health RHT.AX falls 4.9% to A$0.039, its lowest level since August 12
** MedTech co reports annual loss attributable of A$1.7 million ($1.1 million) vs profit of A$169,303 last year
** However, co posts 29% y/y rise in annual revenue to A$11.1 mln
** About 686,104 shares traded, 1.5x the 30-day average
** YTD, stock down 25%, including current session's move
($1 = 1.5389 Australian dollars)
(Reporting by Ananya Verma in Bengaluru)
((ananya.verma@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.